Показано 0 из 0
Дата |
---|
09.04.2024 |
08.04.2024 |
05.04.2024 |
04.04.2024 |
03.04.2024 |
02.04.2024 |
28.03.2024 |
27.03.2024 |
26.03.2024 |
25.03.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
|
|
0.10
|
0.10
|
0.10
|
0.10
|
|
|
|
|
|
|
0.076
|
0.076
|
0.076
|
0.076
|
|
|
|
|
|
|
0.094
|
0.094
|
0.136
|
0.136
|
|
|
|
|
|
|
0.074
|
0.074
|
0.074
|
0.074
|
|
|
|
|
|
|
0.023
|
0.023
|
0.023
|
0.023
|
|
|
|
|
|
|
0.0095
|
0.0095
|
0.0095
|
0.0095
|
|
|
|
|
|
|
0.192
|
0.192
|
0.26
|
0.26
|
|
|
|
|
|
|
0.188
|
0.188
|
0.248
|
0.248
|
|
|
|
|
|
|
0.191
|
0.191
|
0.25
|
0.248
|
|
|
|
|
|
|
0.188
|
0.188
|
0.252
|
0.248
|
|
|
|
|
Antibe Therapeutics Inc., a pharmaceutical development company, originates, develops, and out-licenses patent protected pharmaceuticals in Canada, Europe, and the United States. Its drugs are designed to prevent the gastrointestinal damage and bleeding caused by non-steroidal anti-inflammatory drugs.